This course is intended to facilitate changes in practice with respect to:
• Cardiovascular and thrombotic complications and management of COVID-19
• Optimizing the management of HFpEF, HFrEF, HFmEF and HF with recovered ejection fraction
• Providing the best management of coronary heart disease, lipid disorders, diabetes, STEMI, and thromboembolic disease
• Refining management of ventricular tachycardia
• Optimizing the management of peripheral artery disease
• Improving the use of anti-platelet and anti-coagulation therapy for cardiovascular diseases
• Applying the best considerations of percutaneous interventions for valvular heart disease
• Refining the management of infective endocarditis
Co-Chairs: Nora Goldschlager, MD
Mary Gray, MD
Binh An Phan, MD
Lucas Zier, MD
Priscilla Hsue, MD
Add to Calendar2020-12-04 08:00:002020-12-06 17:00:0037th Annual Advances in Heart Disease
Educational Objectives
This course is intended to facilitate changes in practice with respect to:
• Cardiovascular and thrombotic complications and management of COVID-19
• Optimizing the management of HFpEF, HFrEF, HFmEF and HF with recovered ejection fraction
• Providing the best management of coronary heart disease, lipid disorders, diabetes, STEMI, and thromboembolic disease
• Refining management of ventricular tachycardia
• Optimizing the management of peripheral artery disease
• Improving the use of anti-platelet and anti-coagulation therapy for cardiovascular diseases
• Applying the best considerations of percutaneous interventions for valvular heart disease
• Refining the management of infective endocarditis
Co-Chairs: Nora Goldschlager, MD
Mary Gray, MD
Binh An Phan, MD
Lucas Zier, MD
Priscilla Hsue, MD
[email protected] UCSF CardiologyAmerica/Los_Angelespublic